Solubility of Diclofenac Acid Form from Solid Dispersions

被引：0
|
作者：
I. I. Krasnyuk
L. V. Ovsyannikova
O. I. Nikulina
A. V. Belyatskaya
I. I. Krasnyuk
Yu. Ya. Kharitonov
V. V. Grikh
L. A. Korol’
Yu. A. Obidchenko
A. N. Vorob’ev
机构：
[1] Sechenov First Moscow State Medical University,Research and Education Center of Collective Use
[2] People’s Friendship University of Russia,undefined
来源：
Pharmaceutical Chemistry Journal | 2015年 / 48卷
关键词：
solid dispersions; solubility; NSAID; diclofenac; polyethyleneglycol-1500; polyvinylpyrrolidone-10000; crystallinity; bioavailability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The influence of solid dispersions (SD) on diclofenac solubility was determined by studying diclofenac (acid form) and its SD with polyethyleneglycol-1500 (PEG) and polyvinylpyrrolidone-10000 (PVP). SD formation increased the solubility and dissolution rate of the non-steroidal anti-inflammatory drug (NSAID). Diclofenac solubility from the SD with PVP increased by 2.5 times; from the SD with PEG (solvent evaporation method), by 8 times compared with diclofenac drug substance. A combination of physicochemical methods showed that the improved release of diclofenac from the SD occurred because of reduced crystallinity, formation of drug solid solutions in the polymer matrix, and formation of a colloidal drug solution.
引用
收藏
页码：733 / 737
页数：4
相关论文
共 50 条
  • [41] Solubility improvement of curcumin by crystallization inhibition from polymeric surfactants in amorphous solid dispersions
    Xi, Ziyue
    Fei, Yali
    Wang, Yuxin
    Lin, Qing
    Ke, Qidong
    Feng, Guotai
    Xu, Lu
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 83
  • [42] RELEASE OF IBUPROFEN FROM POLYETHYLENE-GLYCOL SOLID DISPERSIONS - EQUILIBRIUM SOLUBILITY APPROACH
    NAJIB, NM
    SALEM, MAS
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (12) : 2263 - 2275
  • [43] Preparation, characterization and dissolution studies of fast release diclofenac sodium tablets from PVP solid dispersions
    Lamas, Maria C.
    Leonardi, Dario
    Lambri, Osvaldo A.
    Bassani, Georgina
    Barrera, Maria G.
    Bolmaro, Raul E.
    Salomon, Claudio J.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2010, 15 (02) : 162 - 168
  • [44] Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes
    Muhammad Tayyab Ansari
    Kevin T. Batty
    Ijaz Iqbal
    Vivian Bruce Sunderland
    Archives of Pharmacal Research, 2011, 34
  • [45] Improving drug solubility for oral delivery using solid dispersions
    Leuner, C
    Dressman, J
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 47 - 60
  • [46] Effect of Solid Dispersions with Polyethylene Glycol 1500 on the Solubility of Indomethacin
    Krasnyuk, I. I., Jr.
    Kosheleva, T. M.
    Belyatskaya, A. V.
    Krasnyuk, I. I.
    Stepanova, O. I.
    Skovpen, Yu.
    Grikh, V. V.
    Ovsyannikova, L. V.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2018, 52 (03) : 241 - 244
  • [47] Lipid Solid Dispersions for the Aqueous Solubility and Bioavailability Enhancement of Entacapone
    Prasad, R. S.
    Yandrapu, Sarath K.
    Manavalan, R.
    ASIAN JOURNAL OF CHEMISTRY, 2010, 22 (06) : 4549 - 4558
  • [48] SOLID DISPERSIONS: A REVIEW ON DRUG DELIVERY SYSTEM AND SOLUBILITY ENHANCEMENT
    Allawadi, Dharna
    Singh, Neelam
    Singh, Sukhbir
    Arora, Sandeep
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (06): : 2094 - 2105
  • [49] Effect of Solid Dispersions with Polyethylene Glycol 1500 on the Solubility of Indomethacin
    I. I. Krasnyuk
    T. M. Kosheleva
    A. V. Belyatskaya
    I. I. Krasnyuk
    O. I. Stepanova
    Yu. Skovpen
    V. V. Grikh
    L. V. Ovsyannikova
    Pharmaceutical Chemistry Journal, 2018, 52 : 241 - 244
  • [50] In Silico Screening for Solid Dispersions: The Trouble with Solubility Parameters and χFH
    Turpin, Eleanor R.
    Taresco, Vincenzo
    Al-Hachami, Wathiq A.
    Booth, Jonathan
    Treacher, Kevin
    Tomasi, Simone
    Alexander, Cameron
    Burley, Jonathan
    Laughton, Charles A.
    Garnett, Martin C.
    MOLECULAR PHARMACEUTICS, 2018, 15 (10) : 4654 - 4667
12345